{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:01:34Z","timestamp":1740182494339,"version":"3.37.3"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jtocrr.2024.100714","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:41:40Z","timestamp":1724899300000},"page":"100714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rearranged During Transfection Rearrangement Detection by Fluorescence In Situ Hybridization Compared With Other Techniques in NSCLC"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-4085","authenticated-orcid":false,"given":"Anne","family":"Mc Leer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Mondet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Magnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mailys","family":"Mersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Emprou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claire","family":"Toffart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Lantu\u00e9joul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2024.100714_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jtocrr.2024.100714_bib2","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtocrr.2024.100714_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.genet.32.1.495","article-title":"The critical role of chromosome translocations in human leukemias","volume":"32","author":"Rowley","year":"1998","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jtocrr.2024.100714_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/09553002.2019.1625494","article-title":"Correlation between cytogenetic biomarkers obtained from DC and CBMN assays caused by low dose radon exposure in smokers","volume":"95","author":"Meenakshi","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib5","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.3390\/ijms21197108","article-title":"RET receptor tyrosine kinase: role in neurodegeneration, obesity, and cancer","volume":"21","author":"Mahato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtocrr.2024.100714_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2017.175","article-title":"Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes","volume":"15","author":"Drilon","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4143\/crt.2016.424","article-title":"Genetic alterations and their clinical implications in high-recurrence risk papillary thyroid cancer","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jtocrr.2024.100714_bib8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/cncr.29044","article-title":"The RET oncogene in papillary thyroid carcinoma","volume":"121","author":"Prescott","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib9","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2008-0273","article-title":"Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase\/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers","volume":"93","author":"Liu","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jtocrr.2024.100714_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.133645.111","article-title":"A\u00a0transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing","volume":"22","author":"Ju","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/cr.2012.27","article-title":"Identification of RET gene fusion by exon array analyses in \u201cpan-negative\u201d lung cancer from never smokers","volume":"22","author":"Li","year":"2012","journal-title":"Cell Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib14","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2012.44.1477","article-title":"RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer","volume":"30","author":"Wang","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib15","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.21037\/tlcr-20-346","article-title":"Decade in review: a new era for RET-rearranged lung cancers","volume":"9","author":"Choudhury","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non\u2013small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1470-2045(19)30690-4","article-title":"Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1\u20132 trials","volume":"21","author":"Drilon","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.22.00393","article-title":"Selpercatinib in patients with RET fusion\u2013positive non\u2013small-cell lung cancer: updated safety and efficacy from the registrational LIBRETTO-001 Phase I\/II trial","volume":"41","author":"Drilon","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.annonc.2022.08.002","article-title":"Safety and efficacy of pralsetinib in RET fusion\u2013positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial","volume":"33","author":"Griesinger","year":"2022","journal-title":"Ann Oncol"},{"issue":"suppl 15","key":"10.1016\/j.jtocrr.2024.100714_bib20","article-title":"BOS172738, a highly potent and selective RET inhibitor, for the treatment of RET-altered tumors including RET-fusion+ NSCLC and RET-mutant MTC: Phase 1 study results","volume":"39","author":"Schoffski","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lungcan.2015.06.021","article-title":"Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI","volume":"89","author":"Klempner","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/modpathol.2014.107","article-title":"Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma","volume":"28","author":"Lee","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1078-0432.CCR-20-3208","article-title":"A\u00a0performance comparison of commonly used assays to detect RET fusions","volume":"27","author":"Yang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib24","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1002\/cam4.2599","article-title":"Targeted RNA-sequencing assays: a step forward compared to FISH and IHC techniques?","volume":"8","author":"Tachon","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib25","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-10-0851","article-title":"Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment","volume":"16","author":"Camidge","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib27","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/bjc.2014.36","article-title":"RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis","volume":"110","author":"Tsuta","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep42259","article-title":"Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer","volume":"7","author":"Rogers","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtocrr.2024.100714_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jtho.2020.08.011","article-title":"Molecular characterization and clinical outcomes in RET-rearranged NSCLC","volume":"15","author":"Tan","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jtho.2021.01.1619","article-title":"RET fluorescence in situ hybridization analysis is a sensitive but highly unspecific screening method for RET fusions in lung cancer","volume":"16","author":"Radonic","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5858\/arpa.2020-0376-OA","article-title":"Analytical accuracy of RET fusion detection by break-apart fluorescence in situ hybridization","volume":"146","author":"Baker","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.suronc.2018.01.006","article-title":"Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients","volume":"27","author":"Kim","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lungcan.2013.07.009","article-title":"Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma","volume":"82","author":"Go","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/labinvest.2017.124","article-title":"Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma","volume":"98","author":"Piton","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtocrr.2024.100714_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cam4.13","article-title":"RET expression and detection of KIF5B\/RET gene rearrangements in Japanese lung cancer","volume":"1","author":"Sasaki","year":"2012","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtocrr.2024.100714_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.21037\/tlcr-20-549","article-title":"Phase 1\/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)","volume":"10","author":"Takeuchi","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lungcan.2016.09.002","article-title":"Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma","volume":"101","author":"Song","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.lungcan.2013.06.026","article-title":"KIF5B\/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung","volume":"81","author":"Borrelli","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2014.02.007","article-title":"ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features","volume":"84","author":"Pan","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13000-015-0368-z","article-title":"KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas","volume":"10","author":"Kim","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/15384047.2016.1235660","article-title":"Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients","volume":"18","author":"Song","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtocrr.2024.100714_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1373\/clinchem.2016.265314","article-title":"Identification of ALK, ROS1, and RET fusions by a multiplexed mRNA-based assay in formalin-fixed, paraffin-embedded samples from advanced non\u2013small-cell lung cancer patients","volume":"63","author":"Reguart","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtocrr.2024.100714_bib43","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/cncr.30539","article-title":"Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma","volume":"123","author":"Tanaka","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib44","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1158\/1078-0432.CCR-12-0838","article-title":"Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions","volume":"18","author":"Suehara","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jmoldx.2013.11.007","article-title":"A\u00a0single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer","volume":"16","author":"Lira","year":"2014","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jtocrr.2024.100714_bib46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.prp.2018.02.001","article-title":"Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study","volume":"214","author":"Velizheva","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jtocrr.2024.100714_bib47","first-page":"1212","article-title":"Histology and oncogenic driver alterations of lung adenocarcinoma in Chinese","volume":"9","author":"Shang","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib48","first-page":"525","article-title":"Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma","volume":"13","author":"Chen","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.21037\/tlcr-22-202","article-title":"Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients","volume":"11","author":"Feng","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2022.02.005","article-title":"The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies\u2019 integration","volume":"123","author":"Ambrosini-Spaltro","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-2600(16)30322-8","article-title":"Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial","volume":"5","author":"Yoh","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"suppl 16","key":"10.1016\/j.jtocrr.2024.100714_bib52","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1538-7445.AM2020-4256","article-title":"Multiplex fast FISH assay for detecting ROS1, RET and MET aberrations in FFPE specimens using BioView image analysis","volume":"80","author":"Sokolova","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2019.11.022","article-title":"Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: incremental yield of actionable alterations and cost-effectiveness analysis","volume":"139","author":"Tan","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.21037\/tlcr-20-740","article-title":"Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients","volume":"10","author":"Novaes","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/clinem\/dgaa913","article-title":"Pitfalls in RET fusion detection using break-apart FISH probes in papillary thyroid carcinoma","volume":"106","author":"Liu","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jtocrr.2024.100714_bib56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/EJE-14-0930","article-title":"Break\u2013apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET\/PTC rearrangements","volume":"172","author":"Colato","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.annonc.2020.11.021","article-title":"ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research","volume":"32","author":"Belli","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib59","article-title":"Catalog of 5\u2019 fusion partners in RET+ NSCLC Circa 2020","volume":"1","author":"Ou","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2024.100714_bib60","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/JTO.0b013e3182381535","article-title":"Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study","volume":"7","author":"McLeer-Florin","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1183\/09031936.00119914","article-title":"French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas","volume":"46","author":"Lantuejoul","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtocrr.2024.100714_bib62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jtho.2015.09.016","article-title":"Clinicopathological characteristics of RET rearranged lung cancer in European patients","volume":"11","author":"Michels","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100714_bib63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.lungcan.2015.09.022","article-title":"ALK-FISH borderline cases in non-small cell lung cancer: implications for diagnostics and clinical decision making","volume":"90","author":"von Laffert","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100714_bib64","doi-asserted-by":"crossref","first-page":"676","DOI":"10.21037\/tlcr-22-516","article-title":"False positivity in break apart fluorescence in-situ hybridization due to polyploidy","volume":"12","author":"van Gulik","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100714_bib65","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1158\/1078-0432.CCR-14-2683","article-title":"Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches","volume":"21","author":"Drilon","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364324000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364324000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:34:10Z","timestamp":1733618050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364324000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666364324000845"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2024.100714","relation":{},"ISSN":["2666-3643"],"issn-type":[{"type":"print","value":"2666-3643"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rearranged During Transfection Rearrangement Detection by Fluorescence In Situ Hybridization Compared With Other Techniques in NSCLC","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2024.100714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100714"}}